Economic Partnership Agreement & Strategic Partnership Agreement, what is the future for relations between France and Japan?

Economic Partnership Agreement & Strategic Partnership Agreement between the European Union and Japan are a complex subject, even from a legalistic point of view. The aim of this presentation is to analyze several key themes in order to better understand these agreements. First of all, we need to clarify the concept of Economic Partnership Agreement and Strategic Partnership Agreement. Second, it will be necessary to determine their multiple issues and, then, their key principles. After that, it will be useful to present the next steps that these agreements will have.特集Ⅱ：EPA 締結後の日仏関

Approche probabiliste de la durée de vie d'un composite unidirectionnel à matrice métallique en fatigue oligocyclique axiale

Ce travail propose la construction d’un modèle de durée de vie pour un composite unidirectionnel à matrice métallique (SCS-6/Ti6242) soumis à un chargement de fatigue oligocyclique axiale. Ce genre de composite doit être utilisé comme renfort circonférentiel d’une nouvelle génération de compresseur dans les moteurs d’avion : les ANnneaux Aubagés Monoblocs (ANAM). En régime oligocyclique, la ruine du matériau est pilotée par les ruptures de filaments et leurs interactions. L’approche adoptée consiste dans un premier temps à identifier le caractère statistique à rupture in situ des filaments par l’analyse d’un essai de fragmentation. Le report de charge consécutif aux ruptures est ensuite évalué à l’aide de modèles éléments finis en trois dimensions. L’écrouissage cyclique de la matrice métallique et ses conséquences sur le chargement global du renfort est modélisé via une technique d’homogénéisation périodique. Ces trois mécanismes principaux sont alors assemblés pour construire le modèle de durée de vie SIRCUD-3. L’utilisation d’outils numériques parmi lesquels une loi de comportement élasto-viscoplatique pour la matrice titane et une loi d’interface cohésive pour l’interface fibre/matrice améliore la précision des modèles antérieurs. Les durées de vie obtenues à l’aide du code SIRCUD-3 montrent un bon accord avec l’expérience lors des premières confrontations proposées.This work develops a probabilistic approach for the life time of a unidirectional metal matrix composite under axial low cycle fatigue. The SCS-6/Ti6242 composite has to be used as circonferential reinforcement in a new generation of compressor ring in aircraft engines : the BLaded rINGs (BLING). In the low cycle fatigue range, final failure is governed by the fibres breaks and their interactions. The proposed approach is first to evaluate the statistical fracture behaviour of the fibres with the help of an in situ identification method : the single fibre fragmentation test. The load sharing mechanisms are then evaluated around the fibres breaks with the help of a three dimensional finite elements analysis. Periodic homogenization technics are used to model the cyclic plasticity of the metal matrix and its influence on the global load of the fibres. These three main mechanisms are then combinated to establish the life time model SIRCUD-3. Using an elasto-viscoplastic constitutive law for the titanium matrix and a cohesive zone model for the fibre/matrix interface improves the accuracy of the life time predictions compared to previous models. The first life time simulations obtained with the new SIRCUD-3 model show good agreement with experimental data in the low cycle fatigue range

On the possible role of hydrogen in the formation of fatigue striation in a moist atmosphere

Please click Additional Files below to see the full abstrac

Eco-evolutionary dynamics in fragmented landscapes

Peer reviewedPostprin

Multi-walled Carbon Nanotubes, NM-400, NM-401, NM-402, NM-403: Characterisation and Physico-Chemical Properties

In 2011 the JRC launched a Repository for Representative Test Materials that supports both EU and international research projects, and especially the OECD Working Party on Manufactured Nanomaterials' (WPMN) exploratory testing programme "Testing a Representative set of Manufactured Nanomaterials" for the development and collection of data on characterisation, toxicological and ecotoxicological properties, as well as risk assessment and safety evaluation of nanomaterials. The JRC Repository responds to a need for availability of nanomaterial from a single production batch to enhance the comparability of results between different research laboratories and projects. The present report presents the physico-chemical characterisation of the multi-walled carbon nanotubes (MWCNT) from the JRC Repository: NM-400, NM-401, NM-402 and NM-403. NM-400 was selected as principal material for the OECD WPMN testing programme. They are produced by catalytic chemical vapour deposition. Each of these NMs originates from one respective batch of commercially manufactured MWCNT. They are nanostructured, i.e. they consist of more than one graphene layer stacked on each other and rolled together as concentric tubes. The MWCNT NMs may be used as a representative material in the measurement and testing with regard to hazard identification, risk and exposure assessment studies. The results are based on studies by several European laboratories participating to the NANOGENOTOX Joint Action.JRC.I.4-Nanobioscience

HBM4EU chromates study - Overall results and recommendations for the biomonitoring of occupational exposure to hexavalent chromium

Exposure to hexavalent chromium [Cr(VI)] may occur in several occupational activities, e.g., welding, Cr(VI) electroplating and other surface treatment processes. The aim of this study was to provide EU relevant data on occupational Cr(VI) exposure to support the regulatory risk assessment and decision-making. In addition, the capability and validity of different biomarkers for the assessment of Cr(VI) exposure were evaluated. The study involved nine European countries and involved 399 workers in different industry sectors with exposures to Cr(VI) such as welding, bath plating, applying or removing paint and other tasks. We also studied 203 controls to establish a background in workers with no direct exposure to Cr(VI). We applied a cross-sectional study design and used chromium in urine as the primary biomonitoring method for Cr(VI) exposure. Additionally, we studied the use of red blood cells (RBC) and exhaled breath condensate (EBC) for biomonitoring of exposure to Cr(VI). Personal measurements were used to study exposure to inhalable and respirable Cr(VI) by personal air sampling. Dermal exposure was studied by taking hand wipe samples. The highest internal exposures were observed in the use of Cr(VI) in electrolytic bath plating. In stainless steel welding the internal Cr exposure was clearly lower when compared to plating activities. We observed a high correlation between chromium urinary levels and air Cr(VI) or dermal total Cr exposure. Urinary chromium showed its value as a first approach for the assessment of total, internal exposure. Correlations between urinary chromium , Cr(VI) in EBC and Cr in RBC were low, probably due to differences in kinetics and indicating that these biomonitoring approaches may not be interchangeable but rather complementary. This study showed that occupational biomonitoring studies can be conducted successfully by multi-national collaboration and provide relevant information to support policy actions aiming to reduce occupational expo-sure to chemicals

Range Expansion Drives Dispersal Evolution In An Equatorial Three-Species Symbiosis

A-09-14International audienceBackground Recurrent climatic oscillations have produced dramatic changes in species distributions. This process has been proposed to be a major evolutionary force, shaping many life history traits of species, and to govern global patterns of biodiversity at different scales. During range expansions selection may favor the evolution of higher dispersal, and symbiotic interactions may be affected. It has been argued that a weakness of climate fluctuation-driven range dynamics at equatorial latitudes has facilitated the persistence there of more specialized species and interactions. However, how much the biology and ecology of species is changed by range dynamics has seldom been investigated, particularly in equatorial regions. Methodology/Principal Findings We studied a three-species symbiosis endemic to coastal equatorial rainforests in Cameroon, where the impact of range dynamics is supposed to be limited, comprised of two species-specific obligate mutualists –an ant-plant and its protective ant– and a species-specific ant parasite of this mutualism. We combined analyses of within-species genetic diversity and of phenotypic variation in a transect at the southern range limit of this ant-plant system. All three species present congruent genetic signatures of recent gradual southward expansion, a result compatible with available regional paleoclimatic data. As predicted, this expansion has been accompanied by the evolution of more dispersive traits in the two ant species. In contrast, we detected no evidence of change in lifetime reproductive strategy in the tree, nor in its investment in food resources provided to its symbiotic ants. Conclusions/Significance Despite the decreasing investment in protective workers and the increasing investment in dispersing females by both the mutualistic and the parasitic ant species, there was no evidence of destabilization of the symbiosis at the colonization front. To our knowledge, we provide here the first evidence at equatorial latitudes that biological traits associated with dispersal are affected by the range expansion dynamics of a set of interacting species

Genetics of Dispersal

Dispersal is a process of central importance for the ecological and evolutionary dynamics of populations and communities, because of its diverse consequences for gene flow and demography. It is subject to evolutionary change, which begs the question, what is the genetic basis of this potentially complex trait? To address this question, we (i) review the empirical literature on the genetic basis of dispersal, (ii) explore how theoretical investigations of the evolution of dispersal have represented the genetics of dispersal, and (iii) discuss how the genetic basis of dispersal influences theoretical predictions of the evolution of dispersal and potential consequences. Dispersal has a detectable genetic basis in many organisms, from bacteria to plants and animals. Generally, there is evidence for significant genetic variation for dispersal or dispersal-related phenotypes or evidence for the micro-evolution of dispersal in natural populations. Dispersal is typically the outcome of several interacting traits, and this complexity is reflected in its genetic architecture: while some genes of moderate to large effect can influence certain aspects of dispersal, dispersal traits are typically polygenic. Correlations among dispersal traits as well as between dispersal traits and other traits under selection are common, and the genetic basis of dispersal can be highly environment-dependent. By contrast, models have historically considered a highly simplified genetic architecture of dispersal. It is only recently that models have started to consider multiple loci influencing dispersal, as well as non-additive effects such as dominance and epistasis, showing that the genetic basis of dispersal can influence evolutionary rates and outcomes, especially under non-equilibrium conditions. For example, the number of loci controlling dispersal can influence projected rates of dispersal evolution during range shifts and corresponding demographic impacts. Incorporating more realism in the genetic architecture of dispersal is thus necessary to enable models to move beyond the purely theoretical towards making more useful predictions of evolutionary and ecological dynamics under current and future environmental conditions. To inform these advances, empirical studies need to answer outstanding questions concerning whether specific genes underlie dispersal variation, the genetic architecture of context-dependent dispersal phenotypes and behaviours, and correlations among dispersal and other traits.Peer reviewe

BMJ Med

OBJECTIVE: To evaluate the efficacy of covid-19 convalescent plasma to treat patients admitted to hospital for moderate covid-19 disease with or without underlying immunodeficiency (CORIPLASM trial). DESIGN: Open label, randomised clinical trial. SETTING: CORIMUNO-19 cohort (publicly supported platform of open label, randomised controlled trials of immune modulatory drugs in patients admitted to hospital with moderate or severe covid-19 disease) based on 19 university and general hospitals across France, from 16 April 2020 to 21 April 2021. PARTICIPANTS: 120 adults (n=60 in the covid-19 convalescent plasma group, n=60 in the usual care group) admitted to hospital with a positive SARS-CoV2 test result, duration of symptoms 40. MAIN OUTCOME MEASURES: Primary outcomes were proportion of patients with a WHO Clinical Progression Scale score of ≥6 on the 10 point scale on day 4 (higher values indicate a worse outcome), and survival without assisted ventilation or additional immunomodulatory treatment by day 14. Secondary outcomes were changes in WHO Clinical Progression Scale scores, overall survival, time to discharge, and time to end of dependence on oxygen supply. Predefined subgroups analyses included immunosuppression status, duration of symptoms before randomisation, and use of steroids. RESULTS: 120 patients were recruited and assigned to covid-19 convalescent plasma (n=60) or usual care (n=60), including 22 (covid-19 convalescent plasma) and 27 (usual care) patients who were immunocompromised. 13 (22%) patients who received convalescent plasma had a WHO Clinical Progression Scale score of ≥6 at day 4 versus eight (13%) patients who received usual care (adjusted odds ratio 1.88, 95% credible interval 0.71 to 5.24). By day 14, 19 (31.6%) patients in the convalescent plasma group and 20 (33.3%) patients in the usual care group needed ventilation, additional immunomodulatory treatment, or had died. For cumulative incidence of death, three (5%) patients in the convalescent plasma group and eight (13%) in the usual care group died by day 14 (adjusted hazard ratio 0.40, 95% confidence interval 0.10 to 1.53), and seven (12%) patients in the convalescent plasma group and 12 (20%) in the usual care group by day 28 (adjusted hazard ratio 0.51, 0.20 to 1.32). In a subgroup analysis performed in patients who were immunocompromised, transfusion of covid-19 convalescent plasma was associated with mortality (hazard ratio 0.39, 95% confidence interval 0.14 to 1.10). CONCLUSIONS: In this study, covid-19 convalescent plasma did not improve early outcomes in patients with moderate covid-19 disease. The efficacy of convalescent plasma in patients who are immunocompromised should be investigated further. TRIAL REGISTRATION: ClinicalTrials.gov NCT04345991